Clinical Trials Logo

Clinical Trial Summary

To describe the design, methodology and baseline characteristics of the Shanghai Cohort study of Diabetic Eye disease (SCODE) study, a community-based study to determine the prevalence and impact of diabetic eye disease, especially diabetic retinopathy (DR), in adults with diabetes living in Shanghai.


Clinical Trial Description

The Shanghai Cohort study of Diabetic Eye disease (SCODE) was a three-year community-based study to carry out a regular ocular health screening and epidemiological analysis for diabetic eye disease in the approximately 8,000 middle-aged and elderly people with diabetes in Shanghai. Through this study, we hope to understand the prevalence, epidemic trend and the features of risk factors distribution on diabetic eye disease, especially on DR.

Meanwhile, our aims also included estimating the ocular fundus changes and visual impairment associated with different grade of DR. Furthermore, the aim of the present study was to investigate the association between serum and urine biochemical parameters and DR. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03665090
Study type Observational
Source Shanghai Eye Disease Prevention and Treatment Center
Contact
Status Enrolling by invitation
Phase
Start date January 1, 2016
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04380064 - Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy N/A